Literature DB >> 33926035

Pathophysiology and Treatment Strategies of Acute Myopathy and Muscle Wasting after Sepsis.

Robert T Mankowski1, Orlando Laitano2, Thomas L Clanton3, Scott C Brakenridge4.   

Abstract

Sepsis survivors experience a persistent myopathy characterized by skeletal muscle weakness, atrophy, and an inability to repair/regenerate damaged or dysfunctional myofibers. The origins and mechanisms of this persistent sepsis-induced myopathy are likely complex and multifactorial. Nevertheless, the pathobiology is thought to be triggered by the interaction between circulating pathogens and impaired muscle metabolic status. In addition, while in the hospital, septic patients often experience prolonged periods of physical inactivity due to bed rest, which may exacerbate the myopathy. Physical rehabilitation emerges as a potential tool to prevent the decline in physical function in septic patients. Currently, there is no consensus regarding effective rehabilitation strategies for sepsis-induced myopathy. The optimal timing to initiate the rehabilitation intervention currently lacks consensus as well. In this review, we summarize the evidence on the fundamental pathobiological mechanisms of sepsis-induced myopathy and discuss the recent evidence on in-hospital and post-discharge rehabilitation as well as other potential interventions that may prevent physical disability and death of sepsis survivors.

Entities:  

Keywords:  acute muscle wasting; myopathy; sepsis

Year:  2021        PMID: 33926035     DOI: 10.3390/jcm10091874

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  70 in total

Review 1.  Physiotherapy in intensive care: an updated systematic review.

Authors:  Kathy Stiller
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

2.  Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.

Authors:  Brittany Mathias; Amber L Delmas; Tezcan Ozrazgat-Baslanti; Erin L Vanzant; Benjamin E Szpila; Alicia M Mohr; Frederick A Moore; Scott C Brakenridge; Babette A Brumback; Lyle L Moldawer; Philip A Efron
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

3.  Effects of neuromuscular electrical stimulation in critically ill patients: A systematic review and meta-analysis of randomised controlled trials.

Authors:  Y Zayed; B Kheiri; M Barbarawi; A Chahine; L Rashdan; S Chintalapati; G Bachuwa; I Al-Sanouri
Journal:  Aust Crit Care       Date:  2019-05-31       Impact factor: 2.737

Review 4.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

Review 5.  Enhancing Recovery From Sepsis: A Review.

Authors:  Hallie C Prescott; Derek C Angus
Journal:  JAMA       Date:  2018-01-02       Impact factor: 56.272

6.  Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial.

Authors:  Christina Routsi; Vasiliki Gerovasili; Ioannis Vasileiadis; Eleftherios Karatzanos; Theodore Pitsolis; Elli Tripodaki; Vasiliki Markaki; Dimitrios Zervakis; Serafim Nanas
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

7.  Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.

Authors:  M C Monici; M Aguennouz; A Mazzeo; C Messina; G Vita
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

8.  Older Adults Demonstrate Biomarker Evidence of the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS) After Sepsis.

Authors:  Robert T Mankowski; Stephen D Anton; Gabriela L Ghita; Babette Brumback; Dijoia B Darden; Azra Bihorac; Christiaan Leeuwenburgh; Lyle L Moldawer; Philip A Efron; Scott C Brakenridge; Frederick A Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-01-07       Impact factor: 6.591

9.  Rehabilitation for patients with sepsis: A systematic review and meta-analysis.

Authors:  Shunsuke Taito; Mahoko Taito; Masahiro Banno; Hiraku Tsujimoto; Yuki Kataoka; Yasushi Tsujimoto
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

Review 10.  Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.

Authors:  Russell B Hawkins; Steven L Raymond; Julie A Stortz; Hiroyuki Horiguchi; Scott C Brakenridge; Anna Gardner; Philip A Efron; Azra Bihorac; Mark Segal; Frederick A Moore; Lyle L Moldawer
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

View more
  5 in total

Review 1.  Sarcopenia and Mortality Risk of Patients with Sepsis: A Meta-Analysis.

Authors:  Wei Liu; Chenghuan Hu; Shuangping Zhao
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

2.  A Nutraceutical Product Based on a Mixture of Algae and Extra Virgin Olive Oils and Olive Leaf Extract Attenuates Sepsis-Induced Cardiovascular and Muscle Alterations in Rats.

Authors:  Daniel González-Hedström; Álvaro Moreno-Rupérez; María de la Fuente-Fernández; Mario de la Fuente-Muñoz; Marta Román-Carmena; Sara Amor; Ángel Luís García-Villalón; Asunción López-Calderón; Ana Isabel Martín; Teresa Priego; Miriam Granado
Journal:  Front Nutr       Date:  2022-06-20

3.  Exploring the Muscle Metabolomics in the Mouse Model of Sepsis-Induced Acquired Weakness.

Authors:  Yikang Jiang; Qiang Wei; Wei Liu; Qiunan Chen; Xia Chen; Zhongzhen Yuan; Na Luo; Xi Chen; Chuanjiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

Review 4.  Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation.

Authors:  Stefanie Haberecht-Müller; Elke Krüger; Jens Fielitz
Journal:  Biomolecules       Date:  2021-09-08

5.  The impact of hindlimb disuse on sepsis-induced myopathy in mice.

Authors:  Orlando Laitano; Jose Pindado; Isela Valera; Ray A Spradlin; Kevin O Murray; Katelyn R Villani; Jamal M Alzahrani; Terence E Ryan; Philip A Efron; Leonardo F Ferreira; Elisabeth R Barton; Thomas L Clanton
Journal:  Physiol Rep       Date:  2021-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.